PDCD1 and neoplasm: PD-L1 expression varies by tumor type, with: 41% in Esophagus/GEJ SCC, 44–52% in Esophagus/GEJ AC, and 23% in Gastric AC (PD-1 or PD-L1) [63,64,65,66].